alpha-aminopyridine has been researched along with Bacterial Pneumonia in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Benjamin, JT; Blackwell, TS; Cheng, DS; Du, RH; Gleaves, L; Guo, M; Han, W; McKissack, A; Polosukhin, VV; Richmond, BW; van der Meer, R; Zhang, Y | 1 |
Gillissen, A; Häussermann, A | 1 |
1 review(s) available for alpha-aminopyridine and Bacterial Pneumonia
Article | Year |
---|---|
[Diseases of the lung and air passages 2010].
Topics: Administration, Inhalation; Adrenergic beta-Agonists; Aminopyridines; Asthma; Benzamides; Cyclopropanes; Drug Therapy, Combination; Humans; Hypertension, Pulmonary; Indans; Lung Diseases; Lung Neoplasms; Neoplasm Staging; Phosphodiesterase 4 Inhibitors; Pneumonia, Bacterial; Practice Guidelines as Topic; Pulmonary Disease, Chronic Obstructive; Quinolones | 2010 |
1 other study(ies) available for alpha-aminopyridine and Bacterial Pneumonia
Article | Year |
---|---|
Bacterial-derived Neutrophilic Inflammation Drives Lung Remodeling in a Mouse Model of Chronic Obstructive Pulmonary Disease.
Topics: Airway Remodeling; Aminopyridines; Animals; Bacillus; Benzamides; Cyclopropanes; Disease Models, Animal; Mice, Inbred C57BL; Mice, Mutant Strains; Neutrophils; Pneumonia, Bacterial; Pulmonary Disease, Chronic Obstructive; Pulmonary Emphysema; Receptors, Cell Surface | 2018 |